This inventor holds 1 USPTO granted patent. Top assignee: Sphinx Pharmaceuticals Corporation. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: The Innovative Contributions of Jean M Defauw
Introduction
Jean M Defauw is a notable inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit protein kinase C activity. Her work is crucial in addressing various diseases, including inflammatory, cardiovascular, and neoplastic conditions.
Latest Patents
Jean M Defauw holds a patent for N,N'-bis(sulfonamido)-2-amino-4-iminonaphthalen-1-ones and N,N'-Bis(amido)-2-amino-4-iminonaphthalen-1-ones. This patent discloses methods of inhibiting protein kinase C activity by contacting it with an effective amount of her innovative compounds. Additionally, her patent outlines methods for treating animals suspected of suffering from inflammatory, cardiovascular, and neoplastic diseases through the administration of these compounds.
Career Highlights
Jean M Defauw is associated with Sphinx Pharmaceuticals Corporation, where she continues to advance her research and development efforts. Her work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Jean M Defauw's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has the potential to improve treatment options for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile